XS-02

XS-02 · NovaOnco Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XS-02, covering 2024-08-01 to 2024-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XS-02 Capsules in Patients With Advanced Solid Tumors [Phase 1, Phase 2]